From: Lung and general health effects of Toll-like receptor-4 (TLR4)-interacting SPA4 peptide
(A) Blood gas and electrolytes | Unchallenged, untreated | LPS + vehicle | LPS + SPA4 peptide |
pCO2 mmHg | 58.44 (3.28) | 79.27 (3.77)** | 74 (4.36)* |
HCO3 mmol/L | 24.52 (0.61) | 28.25 (0.39)* | 27.48 (1.49) |
tCO2 mmol/L | 26.3 (0.68) | 30.68 (0.42)* | 29.74 (1.60) |
pO2 mmHg | 37.67 (3.77) | 49.2 (4.84) | 43.25 (3.30) |
tHB g/dL | 15.12 (0.25) | 15.02 (0.25) | 14.35 (0.69) |
AnGAP mmol/L | 14.87 (0.26) | 8.91 (0.53)* | 11.76 (2.21) |
Base Excess (mmol/L) | 3.61 (0.63) | 3.11 (0.61) | 3.3 (1.20)a |
Blood pH | 7.267 (0.02) | 7.199 (0.02)* | 7.212 (0.01) |
Na+ mmol/L | 146.4 (0.53) | 141.2 (0.52)**** | 142.6 (0.51)*** |
K+ mmol/L | 4.84 (0.18) | 4.10 (0.17)* | 4.16 (0.17)* |
Cl− mmol/L | 112.3 (0.49) | 108.2 (0.66)** | 108.2 (0.98)** |
(B) Lactate | Unchallenged, untreated | LPS + vehicle | LPS + SPA4 peptide |
In serum (pmol/μl) | 3081 (190.3) | 5647 (343.2)**** | 4684 (239.4)***, # |
In lung (nmol/g lung) | 6931 (1646) | 19,420 (7108) | 10,439 (2248) |
(C) Albumin | Unchallenged, untreated | LPS + vehicle | LPS + SPA4 peptide |
In lung (μg/g lung) | 10,525 (761.1) | 15,882 (997.6)*** | 13,451 (708.8) |